Treatment of HBV infection reduces the risk of hepatocellular carcinoma

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2009年 / 6卷 / 1期
关键词：
D O I：
10.1038/ncpgasthep1304
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [41] The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma
    Blumberg, BS
    [J]. RESEARCH IN VIROLOGY, 1997, 148 (02): : 91 - 94
  • [42] A case of hepatocellular carcinoma in normal liver with no evidence of HBV or HCV infection
    Tanaka, T
    Hoshino, Y
    Hayashi, S
    Tanaka, S
    Tsuruta, K
    Okamoto, A
    Koike, M
    Hattori, N
    [J]. HEPATO-GASTROENTEROLOGY, 1996, 43 (11) : 1390 - 1394
  • [43] Liver resection for hepatocellular carcinoma based on HBV and HCV infection.
    Nakajima, Y
    Shimamura, T
    Haneda, T
    Nakanishi, K
    Tomioka, N
    Okubo, N
    Kimura, J
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1272 - A1272
  • [44] ALCOHOL AND HBV INFECTION AS RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA IN ITALY - A MULTICENTRIC, CONTROLLED-STUDY
    PAGLIARO, L
    SIMONETTI, RG
    CRAXI, A
    SPANO, C
    FILIPPAZZO, MG
    PALAZZO, U
    PATTI, S
    GIANNUOLI, G
    MARRAFFA, A
    COLOMBO, M
    TOMMASINI, M
    BELLENTANI, S
    VILLA, E
    MANENTI, F
    CAPORASO, N
    COLTORTI, M
    DELVECCHIOBLANCO, C
    FARSI, P
    SMEDILE, A
    VERME, G
    [J]. HEPATO-GASTROENTEROLOGY, 1983, 30 (02) : 48 - 50
  • [45] Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
    Ling Li
    Hie-Won Hann
    Shaogui Wan
    Richard S. Hann
    Chun Wang
    Yinzhi Lai
    Xishan Ye
    Alison Evans
    Ronald E. Myers
    Zhong Ye
    Bingshan Li
    Jinliang Xing
    Hushan Yang
    [J]. Scientific Reports, 6
  • [46] Influence of HBV genotype on the risk of hepatocellular carcinoma: mediating roles of different phase of viral infection and epigenetic modifications
    Wu, Wan-Jung
    Kuo, Yi-Chun
    Kao, Wei-Yi
    Yang, Shu-Han
    Wu, Chih-Feng
    Lin, Chih-Lin
    Liu, Chun-Jen
    Huang, Yi-Wen
    Yu, Ming-Whei
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E271 - E271
  • [47] Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
    Li, Ling
    Hann, Hie-Won
    Wan, Shaogui
    Hann, Richard S.
    Wang, Chun
    Lai, Yinzhi
    Ye, Xishan
    Evans, Alison
    Myers, Ronald E.
    Ye, Zhong
    Li, Bingshan
    Xing, Jinliang
    Yang, Hushan
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [48] Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk
    Liu, Shi
    Li, Yongyin
    Sun, Jian
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (15):
  • [49] Entecavir treatment significantly reduces the risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis b
    Lee, Donghyeon
    Lee, Jeong-Hoon
    Cho, Yuri
    Lee, Yun Bin
    Kwon, Jung Hee
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    Kim, Chung Yong
    [J]. HEPATOLOGY, 2012, 56 : 371A - 371A
  • [50] THE RISK OF HEPATOCELLULAR CARCINOMA IN HBV CIRRHOSIS IS AFFECTED BY POLYMORPHISMS OF THE MERTK GENE
    Bronte, F.
    Pipitone, R. M.
    Grimaudo, S.
    Ferraro, D.
    Calvaruso, V.
    Sferrazza, S.
    Pecoraro, G.
    Augugliaro, M.
    Craxi, A.
    Di Marco, V.
    [J]. DIGESTIVE AND LIVER DISEASE, 2014, 46 : E136 - E137
12345